NasdaqGM - Delayed Quote USD

PROCEPT BioRobotics Corporation (PRCT)

68.10

-0.04

(-0.06%)

At close: May 17 at 4:00 PM EDT

67.49

-0.61

(-0.90%)

After hours: May 17 at 6:49 PM EDT

Key Events

Loading Chart for PRCT

9/21 12:03 PM

DELL

Previous Close 68.14
Open 68.05
Bid 68.05 x 100
Ask 68.23 x 100
Day's Range 67.44 - 68.83
52 Week Range 24.83 - 77.00
Volume 488,289
Avg. Volume 574,615
Market Cap (intraday) 3.502B
Beta (5Y Monthly) 0.95
PE Ratio (TTM) --
EPS (TTM) -2.12
Earnings Date Jul 25, 2024 - Jul 29, 2024
Forward Dividend & Yield --
Ex-Dividend Date --
1y Target Est 71.43

PROCEPT BioRobotics Corporation, a surgical robotics company, focuses on developing transformative solutions in urology in the United States and internationally. The company develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). It also designs Aquablation therapy for males suffering from lower urinary tract symptoms due to BPH. PROCEPT BioRobotics Corporation was incorporated in 2007 and is headquartered in San Jose, California.

www.procept-biorobotics.com

626

Full Time Employees

December 31

Fiscal Year Ends

Sector

Medical Devices

Industry

Trailing total returns as of 5/17/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

PRCT

62.49%

S&P 500

11.18%

1-Year Return

PRCT

104.57%

S&P 500

29.04%

3-Year Return

PRCT

94.57%

S&P 500

18.36%

5-Year Return

PRCT

94.57%

S&P 500

18.36%

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

PROCEPT BioRobotics Corporation

68.10

-0.06%

Mkt Cap 3.502B

Industry Medical Devices

60.65

-2.59%

Mkt Cap 2.381B

Industry Medical Devices

TransMedics Group, Inc.

137.98

+2.26%

Mkt Cap 4.545B

Industry Medical Devices

Shockwave Medical, Inc.

330.13

-0.23%

Mkt Cap 12.422B

Industry Medical Devices

Profound Medical Corp.

8.29

-3.15%

Mkt Cap 202.516M

Industry Medical Devices

Inspire Medical Systems, Inc.

155.22

-2.40%

Mkt Cap 4.612B

Industry Medical Devices

Integer Holdings Corporation

120.92

+1.61%

Mkt Cap 4.051B

Industry Medical Devices

Tandem Diabetes Care, Inc.

47.30

+0.79%

Mkt Cap 3.055B

Industry Medical Devices

Inari Medical, Inc.

45.75

-1.19%

Mkt Cap 2.66B

Industry Medical Devices

Treace Medical Concepts, Inc.

5.0000

-11.19%

Mkt Cap 310.041M

Industry Medical Devices

Glaukos Corporation

109.79

-0.56%

Mkt Cap 5.53B

Industry Medical Devices

Valuation Measures

As of 5/17/2024

Market Cap

3.50B
Enterprise Value

3.36B
Trailing P/E

--
Forward P/E

--
PEG Ratio (5yr expected)

--
Price/Sales (ttm)

21.23
Price/Book (mrq)

13.26
Enterprise Value/Revenue

21.48
Enterprise Value/EBITDA

--

Financial Highlights

Profitability and Income Statement

Profit Margin

-66.12%
Return on Assets (ttm)

-20.31%
Return on Equity (ttm)

-47.29%
Revenue (ttm)

156.33M
Net Income Avi to Common (ttm)

-103.37M
Diluted EPS (ttm)

-2.12

Balance Sheet and Cash Flow

Total Cash (mrq)

225.58M
Total Debt/Equity (mrq)

31.55%
Levered Free Cash Flow (ttm)

-99.36M

PRCT does not have Company Insights

RXST RxSight, Inc.

60.65

-2.59%

TMCI Treace Medical Concepts, Inc.

5.0000

-11.19%

FNA Paragon 28, Inc.

7.66

-3.89%

SGHT Sight Sciences, Inc.

5.34

-8.09%

NUVL Nuvalent, Inc.

70.88

-2.42%

TYRA Tyra Biosciences, Inc.

18.26

-4.40%

CTKB Cytek Biosciences, Inc.

6.10

-1.29%

CVRX CVRx, Inc.

8.29

+2.60%

PRVA Privia Health Group, Inc.

16.90

-0.59%

AXNX Axonics, Inc.

67.55

-0.18%

LUNG Pulmonx Corporation

9.00

-0.55%

SIBN SI-BONE, Inc.

14.92

-1.39%

NPCE NeuroPace, Inc.

8.17

-4.56%

IMCR Immunocore Holdings plc

53.29

-1.77%

ACLX Arcellx, Inc.

53.62

+1.57%

HRMY Harmony Biosciences Holdings, Inc.

29.03

-0.96%